Tag Archives | Dow Chemical

Dow right.jpg

Dow pays $78.97/share for Rohm & Haas

The blog has always had enormous respect for Dow. This was due to their ability to manage unconventional risks, in a way that other chemical companies (such as the blog’s former employer, ICI), found impossible. Even when things went wrong, they always had a Plan B, which allowed them to exit on a sensible basis. […]

Continue Reading
Liveris.jpg

Arise, Sir Evil?

Apparently its not just Jim Cramer who is less than happy with the current performance of Dow CEO, Andrew Liveris. The New York Times notes that merger arbitrageurs on Wall Street have started to spell his surname backwards, and re-christened him accordingly.

Continue Reading
Teessidea left.jpg

Resilience, team-work, key to survival

Last week, the blog spent 2 days at Wilton in the UK, one of the world’s largest and most integrated chemical manufacturing sites. It also contains some of the world’s major companies, including SABIC, Dow, INEOS, Huntsman and Lucite. The mood was downbeat, as one would expect with operating rates at historically low levels. Critically, […]

Continue Reading
Cramer.jpg

Cramer hits at Dow’s Liveris

The credibility of some chemical industry CEO’s seems to be under increasing attack, due to their apparent failure to develop proper contingency plans in advance of the current recession. One example this week comes from the USA, where Jim Cramer is one of the most well-known business TV commentators. He suggests that Dow’s CEO, Andrew […]

Continue Reading

Dow Chemical moves to Plan B

A month ago, after the collapse of the K-Dow deal, the blog suggested that Dow would need to move quickly to a Plan B. It added that “nobody would be very surprised if it now sought to renegotiate the proposed Rohm & Haas acquisition”. This now seems to be underway, judging by two pieces of […]

Continue Reading
Dow right.jpg

Dow’s debt ratings cut – could hit junk status

Over the last few weeks, INEOS had to scramble to get a covenant waiver from its lenders, and Lyondell went into Chapter 11. Now Dow’s debt is facing a potential cut to junk status from the main ratings agencies. Dow’s rating has already been cut, following the collapse of the K-Dow deal with Kuwait. And […]

Continue Reading
Dow right.jpg

Kuwait “scraps” K-Dow JV

2008 has not been a good year for M&A in the chemical sector. First, there was the collapse of Hexion’s Huntsman acquisition. Today, the Kuwait government has signalled its intention to “scrap” its $17.4bn deal with Dow to form K-Dow. This is a quite extraordinary decision by a major Middle East government, especially as it […]

Continue Reading
Dow Dec08.jpg

Dow cuts jobs, sets out future focus

Yesterday, Dow announced its new structure post the K-Dow JV and the planned acquisition of Rohm & Haas. This covered two main elements: • Implementation of November’s cost reduction announcement • Dow’s new organisation (the chart above) The cost reductions were severe, with a headline 11% of staff facing redundancy. 20 plants in “high-cost areas” […]

Continue Reading

Dow, PIC, finalise K-Dow deal

Foresight, and long-term relationships, have paid off for Dow. Yesterday, CEO Andrew Liveris announced that a binding agreement has now been signed with Kuwait’s PIC to form K-Dow Petrochemicals. PIC will pay $2bn less for their stake than originally agreed a year ago. This represents an exceptionally good outcome for Dow, given what has happened […]

Continue Reading
BASF.jpg

BASF warns on 2009

Back in August, the blog noted that BASF chairman Jurgen Hambrecht was forecasting that “the world will still continue to grow respectably”, although he foresaw a temporary slowdown into H1 2009. Yesterday, however, this mood of relative optimism had disappeared as BASF announced Q3 results. Hambrecht is now forecasting, along with Dow’s Andrew Liveris, that […]

Continue Reading